TY  - JOUR
AU  - Contreras, Laura
AU  - Rodriguez-Gil, Alfonso
AU  - Muntane, Jordi
AU  - de-la-Cruz, Jesus
PY  - 2022
DO  - 10.3390/cancers14051204
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20877
T2  - Cancers
AB  - Hepatocellular carcinoma (HCC) is one of the most frequent and essentially incurable cancers in its advanced stages. The tyrosine kinase inhibitor Sorafenib (Sfb) remains the globally accepted treatment for advanced HCC. However, the extent of its...
LA  - en
PB  - MDPI AG
KW  - RNA synthesis
KW  - RNA-Seq
KW  - Sorafenib
KW  - gene ontology
KW  - hepatocellular carcinoma cell line
KW  - Carcinoma, Hepatocellular
KW  - Sorafenib
KW  - Liver Neoplasms
KW  - Tyrosine Kinase Inhibitors
KW  - Hepatoblastoma
KW  - Transcriptome
KW  - Proteostasis
KW  - Circadian Clocks
TI  - Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells.
TY  - research article
VL  - 14
ER  -